Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-4096

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-4096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Tab Usp 20mg (Atorvastatin 20mg 1000s Container Label)

Atorvastatin Calcium Tab Usp 20mg (Atorvastatin 20mg 1000s Container Label)
This description provides detailed information about a specific medication named Atorvastatin Calcium Tab. USP 20, a generic for Lipitor. The text includes the dosage, ingredients, manufacturer (MSN Laboratories Pvt. Ltd.), storage instructions, and cautionary notes about its usage. It also emphasizes the importance of keeping the medication out of reach of children and the prohibition of transferring it to anyone other than the prescribed patient. The oval white tablet is imprinted with specific markings, and the text highlights that it is for prescription use only.*
FDA Label Image

Atorvastatin-figure-01 (Atorvastatin Figure 01)

Atorvastatin-figure-01 (Atorvastatin Figure 01)
This is a table showing cumulative incidence (%) over the years for Atorvastatin and Placebo. The data provided suggests a decrease in cumulative incidence as the years progress, with Atorvastatin and Placebo showing different efficacy levels over time.*
FDA Label Image

Atorvastatin-figure-02 (Atorvastatin Figure 02)

Atorvastatin-figure-02 (Atorvastatin Figure 02)
This text provides information on the Cumulative Hazard (%) of Placebo and Atorvastatin over a period of four years. It shows a Hazard Ratio (HR) of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. The data includes the time to the first primary endpoint over the four years of follow-up.*
FDA Label Image

Atorvastatin-figure-03 (Atorvastatin Figure 03)

Atorvastatin-figure-03 (Atorvastatin Figure 03)
This text provides information on different doses of Atorvastatin (10 mg and 80 mg) and includes a measure of treatment effect. It also mentions the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.